Pfizer Inc.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Total Cash from Operations: $28.60B
| Line Item | Value | % of Total |
|---|---|---|
| Stock Repurchases | $4.12B | 14.4% |
| Other Financing | $3.89B | 13.6% |
| Working Capital | $5.70B | 19.9% |
| Other | $8.00B | 28.0% |
| Net Cash Flow | $6.90B | 24.1% |